Validation of peptide peaks specific for Group B Streptococcus with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
黄莲芬,钟华敏,蒋莹,梁文怡,邓秋连,谢永强,高坎坎,关小珊,刘海英,谌亚星,陈光炼
DOI: https://doi.org/10.3877/cma.j.issn.1674-1358.2021.03.011
2021-01-01
Abstract:Objective:Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis was applied to verify the characteristic peptide peaks of group B Streptococcus (GBS) protein fingerprints for sequence types (ST), serotypes and positive "D-zone test" , providing evidence for rapid GBS subtyping and effective diagnosis and treatment.Methods:Total of 237 GBS isolates were collected from multicenter neonatal invasive infections in China from January 2015 to December 2017 with known STs and serotypes, whose GBS peptide fingerprints were collected by Bruker microbial mass spectrometer, and the characteristic peaks were analyzed by FlexAnalysis 3.0, also the disk diffusion method was used for analysis of erythromycin and clindamycin resistance as well as erythromycin-induced clindamycin resistance.Results:Molecular type-correlated characteristic peptide peaks: m/z 7 625 was not found in all 237 strains of GBS, but 48.3% (41/85) strains of ST17 showed a peptide peak around m/z 7 620; all strains of ST1 (2 strains) showed presence of m/z 6 250 and absence of m/z 6 888 (m/z 6 250+/6 888-), which was also found in all strains of ST10 (31 strains), ST2 (2 strains), ST4 (1 strain), ST156 (1 strain) and ST579 (1 strain). Serotype-correlated peptide peaks: m/z 6 891 was not only present in serotype Ⅲ (96.4%, 133/138) and Ⅰb (81.2%, 56/69), but also common inⅠa (90.5%, 19/21) and Ⅴ strains (87.5%, 7/8), suggesting m/z 6 891 peptide peak had no specificity for serotypes; m/z 7 620 was detected with low intensity in 29.7% Ⅲ GBS (41/138), all of which belonged to ST17 subclone, m/z 7 620 was occasionally existed in other serotypes including Ⅴ (12.5%, 1/8), Ⅰa (9.5%, 2/21) and Ⅰb (2.9%, 2/69), with a sensitivity of 48.2% and specificity of 96.71% for Ⅲ/ST17 GBS. Positive "D-zone test" -associated peptide peaks: 33.76% (80/237) strains were sensitive to clindamycin with resistance or intermediate-resistance to erythromycin, of which 77.5% (62/ 80) were D-test positive. D-test positive rates of the main subtype clone were ST10/Ⅰb (100%, 9/9), ST12/Ⅰb or ST12/Ⅲ (100%, 13/13), ST17/Ⅲ (90%, 27/30), ST19/Ⅲ (40%, 4/10), ST23/Ⅰa (16.67%, 1/6) sequentially, and the D-test positive rate of ST10, ST12 and ST17 subtypes was high (94.23%, 49/52).Conclusions:Peptide peak pairs (m/z 6 250+/ 6 888-) was specific to STs including ST1, ST10 and a few rare ST types, while m/z 6 891 peptide peak was common in different serotypes but not specific for Ⅲ/Ⅰb; m/z 7 620 was the characteristic peptide peak for Ⅲ/ST17 lineage, suggesting it could be used for rapid identification of hypervirulent GBS. D test was positive in all ST10 and ST12, as well as 90% ST17 GBS strains, indicating their ST characteristic peptide peaks could be taken for prediction of positive D-test.